Interestingly, a proband among the PCGC HLHS patients was transheterozygous for mutations in RPL15 and TEAD4 (Jin et al., 2017), making this an interesting disease candidate pair. This evidence concerns the gene TEAD4 and hypoplastic left heart syndrome.